Interaction Guide · Research summary

Can I take Hypericum Perforatum with Trimipramine?

Review Hypericum Perforatum with Trimipramine: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Trimipramine specifically warns about St John’s wort and serotonin syndrome. Discuss any use with the prescriber; reduced trimipramine absorption and a protective timing gap are not established.

What this answer covers

Oral Hypericum perforatum with trimipramine maleate capsules.

Supplement or preparation
Hypericum perforatum
Medication ingredient
trimipramine

The label names the herb

Trimipramine explicitly includes St John’s wort among serotonergic agents of concern. Its mechanism need not be assumed identical to other antidepressants to apply its own warning.

Metabolism evidence uses other medicines

One St John’s wort extract lowered alprazolam exposure, while a low-hyperforin product had no relevant effect in probe studies. These do not establish the magnitude or direction of a trimipramine interaction.

Avoid an invented timing solution

Do not increase trimipramine to compensate for assumed reduced absorption. Bring the herb’s extract and amount to the prescriber; a gap has not been shown to resolve serotonin concerns.

Recognize concerning symptoms

Seek urgent medical care for a combination of agitation or confusion, fever or heavy sweating, tremor, muscle rigidity or repeated twitching. These can be signs of serotonin syndrome; a single nonspecific symptom does not establish the diagnosis.

Evidence and practical considerations

Side effects & toxicity

Conditional exact-label serotonergic precaution; reduced absorption/effectiveness remains insufficiently established.

Exact scope
Oral Hypericum perforatum with trimipramine maleate capsules. with Exact oral trimipramine maleate capsules. RxNorm IN10834 / PIN71532 maleate; mesylate PIN236189 is distinct. Oral maleate capsules only.
Medication form and route
oral
Timing or duration
Source-specific single-dose, repeated-dose and observational exposures distinguished.

What remains uncertain

  • No exact trimipramine co-use PK study identified; other-drug probe results differ by extract.

Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed oral trimipramine.

Label describes a sedative component and explicitly names tryptophan and St John’s wort in serotonin warnings. Cardiovascular and anticholinergic precautions apply.

How this applies: RxNorm IN10834 / PIN71532 maleate; mesylate PIN236189 is distinct. Oral maleate capsules only.

No universal supplement interval, event rate or preparation equivalence established.

Source 2: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Twelve healthy volunteers in an open-label fixed-order crossover.

Alprazolam exposure fell about one-half and clearance increased; elimination half-life shortened.

How this applies: Preparation-specific original evidence; no untested antidepressant or route transfer.

Single extract and short exposure, healthy volunteers; no anxiety-treatment failure endpoint. Does not imply reduced gut absorption or transfer to predominantly conjugated benzodiazepines.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Healthy participants in randomized placebo-controlled studies.

Changes in probe exposures were small and judged clinically irrelevant; hyperforin levels were below quantification.

How this applies: Preparation-specific original evidence; no untested antidepressant or route transfer.

Preparation-specific result, not permission to assume all retail products are low-hyperforin or all doses safe.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Current exact available claims adjudicated using original captures and explicit identity and comparator limits.
Research summary published

Article revision: 2a8d7c4dd5e6e0c4

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.